The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease Risk
Open accessAbstract
BACKGROUND: The use of direct-to-consumer genomewide profiling to assess disease risk is controversial, and little is known about the effect of this technology on consumers. We examined the psychological, behavioral, and clinical effects of risk scanning with the Navigenics Health Compass, a commercially available test of uncertain clinical validity and utility. METHODS: We recruited subjects from health and technology companies who elected to purchase the Health Compass at a discounted rate. Subjects reported any changes in symptoms of anxiety, intake of dietary fat, and exercise behavior at a mean (±SD) of 5.6±2.4 months after testing, as compared with baseline, along with any test-related distress and the use of health-screening tests. RESULTS: From a cohort of 3639 enrolled subjects, 2037 completed follow-up. Primary analyses showed no significant differences between baseline and follow-up in anxiety symptoms (P=0.80), dietary fat intake (P=0.89), or exercise behavior (P=0.61). Secondary analyses revealed that test-related distress was positively correlated with the average estimated lifetime risk among all the assessed conditions (β=0.117, P<0.001). However, 90.3% of subjects who completed follow-up had scores indicating no test-related distress. There was no significant increase in the rate of use of screening tests associated with genomewide profiling, most of which are not considered appropriate for screening asymptomatic persons in any case. CONCLUSIONS: In a selected sample of subjects who completed follow-up after undergoing consumer genomewide testing, such testing did not result in any measurable short-term changes in psychological health, diet or exercise behavior, or use of screening tests. Potential effects of this type of genetic testing on the population at large are not known. (Funded by the National Institutes of Health and Scripps Health.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1970) · Cited by 24,983
Jacobson, N. S., & Truax, P. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.59.1.12 · Cited by 7,770
A simple method to assess exercise behavior in the community.
Godin, G., & Shephard, R. J. (1985) · PubMed · Cited by 3,824
The Impact of Event Scale: Revised
Weiss, D. S. (2007) · International and Cultural Psychology Series · doi:10.1007/978-0-387-70990-1_10 · Cited by 2,996
Psychometric properties of the Impact of Event Scale—Revised
Creamer, M., Bell, R., & Failla, S. (2003) · Behaviour Research and Therapy · doi:10.1016/j.brat.2003.07.010 · Cited by 1,947
A simultaneous evaluation of 10 commonly used physical activity questionnaires
JACOBS, D. R., AINSWORTH, B. E., HARTMAN, T. J., & LEON, A. S. (1993) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-199301000-00012 · Cited by 1,675
A rapid food screener to assess fat and fruit and vegetable intake
Block, G., Gillespie, C., Rosenbaum, E. H., & Jenson, C. (2000) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(00)00119-7 · Cited by 565
Disclosure of APOE Genotype for Risk of Alzheimer's Disease
Green, R. C., Roberts, J. S., Cupples, L. A., Relkin, N. R., Whitehouse, P. J., Brown, T., Eckert, S. L., Butson, M., Sadovnick, A. D., Quaid, K. A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809578 · Cited by 554
An agenda for personalized medicine
Ng, P. C., Murray, S. S., Levy, S., & Venter, J. C. (2009) · Nature · doi:10.1038/461724a · Cited by 330
A systematic review of perceived risks, psychological and behavioral impacts of genetic testing
Heshka, J. T., Palleschi, C., Howley, H., Wilson, B., & Wells, P. S. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e31815f524f · Cited by 328
An Unwelcome Side Effect of Direct-to-Consumer Personal Genome Testing: Raiding the Medical Commons
McGuire, A. L., & Burke, W. (2008) · JAMA · doi:10.1001/jama.2008.803 · Cited by 250
Prophylactic Surgery Decisions and Surveillance Practices One Year Following BRCA1/2 Testing
Lerman, C., Hughes, C., Croyle, R. T., Main, D., Durham, C., Snyder, C., Bonney, A., Lynch, J. F., Narod, S. A., & Lynch, H. T. (2000) · Preventive Medicine · doi:10.1006/pmed.2000.0684 · Cited by 248
Botkin, J. R., Smith, K. R., Croyle, R. T., Baty, B. J., Wylie, J. E., Dutson, D., Chan, A., Hamann, H. A., Lerman, C., McDonald, J., et al. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.10102 · Cited by 197
Roberts, J. S., Cupples, L. A., Relkin, N. R., Whitehouse, P. J., Green, R. C., & for the REVEAL (Risk Evaluation and Education for Alzheimer’s Disease) Study Group (2005) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988705281883 · Cited by 150
Consumer perceptions of direct-to-consumer personalized genomic risk assessments
Bloss, C. S., Ornowski, L., Silver, E., Cargill, M., Vanier, V., Schork, N. J., & Topol, E. J. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181eb51c6 · Cited by 130
Self-citationCollins, V., Meiser, B., Ukoumunne, O. C., Gaff, C., John, D. J. S., & Halliday, J. L. (2007) · Genetics in Medicine · doi:10.1097/gim.0b013e31804b45db · Cited by 83
Cited by
The personal and clinical utility of polygenic risk scores
Torkamani, A., Wineinger, N. E., & Topol, E. J. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0018-x · Cited by 1,623
Self-citationKilpeläinen, T. O., Qi, L., Brage, S., Sharp, S. J., Sonestedt, E., Demerath, E., Ahmad, T., Mora, S., Kaakinen, M., Sandholt, C. H., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001116 · Cited by 559
Genetics of breast cancer: a topic in evolution
Shiovitz, S., & Korde, L. A. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv022 · Cited by 525
Point-of-Care Diagnostics: Recent Developments in a Connected Age
Nayak, S., Blumenfeld, N. R., Laksanasopin, T., & Sia, S. K. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04630 · Cited by 508
Berg, J. S., Khoury, M. J., & Evans, J. P. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e318220aaba · Cited by 490
Metadata
- Authors
- Bloss, C. S., Schork, N. J., & Topol, E. J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-02-10
- Volume
- 364
- Issue
- 6
- Pages
- 524-534
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2153483268
- Cited by
- 562
- References
- 16
- FWCI
- 47.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.